FMI suggests the synbiotic blend market was valued at USD 1.3 billion in 2025, increased to USD 1.4 billion in 2026, and is projected to reach USD 2.7 billion by 2036, reflecting a 6.8% CAGR during 2026 to 2036. By segment, capsules & tablets lead the product form category with a 46% share in 2026, while digestive health dominates the application segment with a 52% share in 2026.